Breast cancer 1 early onset (BRCA1); BRCA2; cyclin dependent kinase 1 (CDK1; CDC2); poly(ADP-ribose) polymerase (PARP) BriefCommunication Pages: 760 - 760
Ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) (RAC1) BriefCommunication Pages: 764 - 764
Tumor necrosis factor–related apoptosis-inducing ligand (TRAIL); tumor necrosis factor–related apoptosis-inducing ligand receptor 1 (TRAIL-R1); TRAIL-R2 BriefCommunication Pages: 765 - 765
Aurora kinase A (AURKA; Aurora-A); polycystic kidney disease 2 (PKD2) BriefCommunication Pages: 769 - 769
Distal-less homeobox 3 (Dlx3) mutant mice as a model for skin inflammation BriefCommunication Pages: 773 - 773
Transgenic mouse model of hemophilia as a screen for immunogenicity of Factor VIII–based hemophilia therapies BriefCommunication Pages: 774 - 774
Adeno-associated virus serotype 8 (AAV8) for delivery of retinal gene therapy to treat blindness BriefCommunication Pages: 775 - 775
3D structure of human histamine H1 receptor (HRH1) to aid development of antagonists BriefCommunication Pages: 776 - 776
Adeno-associated virus (AAV)-mediated zinc finger nuclease (ZFN) delivery for in vivo gene editing BriefCommunication Pages: 777 - 777
Live, attenuated Plasmodium arrested at late-stage liver development to prevent malaria infection BriefCommunication Pages: 779 - 779